Literature DB >> 23726246

Simultaneous quantification of Δ(9)-tetrahydrocannabinol, 11-nor-9-carboxy-tetrahydrocannabinol, cannabidiol and cannabinol in oral fluid by microflow-liquid chromatography-high resolution mass spectrometry.

Marta Concheiro1, Dayong Lee, Elena Lendoiro, Marilyn A Huestis.   

Abstract

Δ(9)-Tetrahydrocannabinol (THC) is the primary target in oral fluid (OF) for detecting cannabis intake. However, additional biomarkers are needed to solve interpretation issues, such as the possibility of passive inhalation by identifying 11-nor-9-carboxy-THC (THCCOOH), and determining recent cannabis smoking by identifying cannabidiol (CBD) and/or cannabinol (CBN). We developed and comprehensively validated a microflow liquid chromatography (LC)-high resolution mass spectrometry method for simultaneous quantification of THC, THCCOOH, CBD and CBN in OF collected with the Oral-Eze(®) and Quantisal™ devices. One milliliter OF-buffer solution (0.25mL OF and 0.5mL of Oral-Eze buffer, 1:3 dilution, or 0.75mL Quantisal buffer, 1:4 dilution) had proteins precipitated, and the supernatant subjected to CEREXPolycromTHC solid-phase extraction (SPE). Microflow LC reverse-phase separation was achieved with a gradient mobile phase of 10mM ammonium acetate pH 6 and acetonitrile over 10min. We employed a Q Exactive high resolution mass spectrometer, with compounds identified and quantified by targeted-MSMS experiments. The assay was linear 0.5-50ng/mL for THC, CBD and CBN, and 15-500pg/mL for THCCOOH. Intra- and inter-day and total imprecision were <10.8%CV and bias 86.5-104.9%. Extraction efficiency was 52.4-109.2%, process efficiency 12.2-88.9% and matrix effect ranged from -86 to -6.9%. All analytes were stable for 24h at 5°C on the autosampler. The method was applied to authentic OF specimens collected with Quantisal and Oral-Eze devices. This method provides a rapid simultaneous quantification of THCCOOH and THC, CBD, CBN, with good selectivity and sensitivity, providing the opportunity to improve interpretation of cannabinoid OF results by eliminating the possibility of passive inhalation and providing markers of recent cannabis smoking. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23726246      PMCID: PMC3918468          DOI: 10.1016/j.chroma.2013.04.071

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  19 in total

1.  Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis.

Authors:  Garry Milman; David M Schwope; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chim Acta       Date:  2012-01-20       Impact factor: 3.786

2.  Analysis of tetrahydrocannabinol and its metabolite, 11-nor-Δ⁹-tetrahydrocannabinol-9-carboxylic acid, in oral fluid using liquid chromatography with tandem mass spectrometry.

Authors:  Cynthia Coulter; Margaux Garnier; Christine Moore
Journal:  J Anal Toxicol       Date:  2012-04-24       Impact factor: 3.367

3.  Cannabinoids in oral fluid following passive exposure to marijuana smoke.

Authors:  Christine Moore; Cynthia Coulter; Donald Uges; James Tuyay; Susanne van der Linde; Arthur van Leeuwen; Margaux Garnier; Jonathan Orbita
Journal:  Forensic Sci Int       Date:  2011-07-18       Impact factor: 2.395

4.  Simultaneous determination of Δ9-tetrahydrocannabinol and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in oral fluid using isotope dilution liquid chromatography tandem mass spectrometry.

Authors:  Pin Duo Lee; Yuan-Jhe Chang; Keh-Liang Lin; Yan-Zin Chang
Journal:  Anal Bioanal Chem       Date:  2011-11-27       Impact factor: 4.142

5.  Detection of the marijuana metabolite 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens and its contribution to positive results in screening assays.

Authors:  Christine Moore; Wayne Ross; Cynthia Coulter; Laura Adams; Sumandeep Rana; Michael Vincent; James Soares
Journal:  J Anal Toxicol       Date:  2006-09       Impact factor: 3.367

6.  Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry.

Authors:  Garry Milman; Allan J Barnes; Ross H Lowe; Marilyn A Huestis
Journal:  J Chromatogr A       Date:  2010-01-04       Impact factor: 4.759

7.  Ultra-sensitive measurements of 11-Nor-δ(9)-tetrahydrocannabinol-9-carboxylic acid in oral fluid by microflow liquid chromatography-tandem mass spectrometry using a benchtop quadrupole/orbitrap mass spectrometer.

Authors:  Xiang He; Marta Kozak; Subodh Nimkar
Journal:  Anal Chem       Date:  2012-08-27       Impact factor: 6.986

8.  Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.

Authors:  M A Huestis; J E Henningfield; E J Cone
Journal:  J Anal Toxicol       Date:  1992 Sep-Oct       Impact factor: 3.367

Review 9.  Marijuana neurobiology and treatment.

Authors:  Ahmed Elkashef; Frank Vocci; Marilyn Huestis; Margaret Haney; Alan Budney; Amanda Gruber; Nady el-Guebaly
Journal:  Subst Abus       Date:  2008       Impact factor: 3.716

10.  The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users.

Authors:  Ryan Vandrey; Maxine L Stitzer; Miriam Z Mintzer; Marilyn A Huestis; Jeannie A Murray; Dayong Lee
Journal:  Drug Alcohol Depend       Date:  2012-08-22       Impact factor: 4.492

View more
  4 in total

1.  Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers.

Authors:  Sebastien Anizan; Garry Milman; Nathalie Desrosiers; Allan J Barnes; David A Gorelick; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2013-08-17       Impact factor: 4.142

2.  Nonsmoker Exposure to Secondhand Cannabis Smoke. III. Oral Fluid and Blood Drug Concentrations and Corresponding Subjective Effects.

Authors:  Edward J Cone; George E Bigelow; Evan S Herrmann; John M Mitchell; Charles LoDico; Ronald Flegel; Ryan Vandrey
Journal:  J Anal Toxicol       Date:  2015-07-02       Impact factor: 3.367

Review 3.  Current knowledge on cannabinoids in oral fluid.

Authors:  Dayong Lee; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2013-08-25       Impact factor: 3.345

4.  Development and quantitative evaluation of a high-resolution metabolomics technology.

Authors:  Xiaojing Liu; Zheng Ser; Jason W Locasale
Journal:  Anal Chem       Date:  2014-01-28       Impact factor: 6.986

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.